These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 449003)

  • 41. A new test statistic for the Kodlin-Standish drug surveillance model.
    Ury HK
    Comput Biomed Res; 1972 Oct; 5(5):561-75. PubMed ID: 4634377
    [No Abstract]   [Full Text] [Related]  

  • 42. Letter: Measurement of side effects of drugs.
    Herxheimer A
    Br Med J; 1974 Aug; 3(5928):470. PubMed ID: 4414288
    [No Abstract]   [Full Text] [Related]  

  • 43. The wise use of drugs.
    Modell W
    JAMA; 1966 May; 196(5):415-7. PubMed ID: 5952221
    [No Abstract]   [Full Text] [Related]  

  • 44. Error in medicine.
    Cunnington JP
    JAMA; 1995 Aug; 274(6):458; author reply 460-1. PubMed ID: 7629947
    [No Abstract]   [Full Text] [Related]  

  • 45. Letter: Implications of the statement: No side effects were observed.
    Rümke CL
    N Engl J Med; 1975 Feb; 292(7):372-3. PubMed ID: 1117973
    [No Abstract]   [Full Text] [Related]  

  • 46. Principles of epidemiological research on drug effects.
    Gargiullo PM; Kramarz P; DeStefano F; Chen RT
    Lancet; 1999 Feb; 353(9151):501. PubMed ID: 9989750
    [No Abstract]   [Full Text] [Related]  

  • 47. Mild cutaneous reactions to drugs.
    Crisafulli G; Franceschini F; Caimmi S; Bottau P; Liotti L; Saretta F; Bernardini R; Cardinale F; Mori F; Caffarelli C
    Acta Biomed; 2019 Jan; 90(3-S):36-43. PubMed ID: 30830060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
    Danan G; Teschke R
    Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference.
    Théophile H; André M; Miremont-Salamé G; Arimone Y; Bégaud B
    Drug Saf; 2013 Oct; 36(10):1033-44. PubMed ID: 23828659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A qualitative study evaluating causality attribution for serious adverse events during early phase oncology clinical trials.
    Mukherjee SD; Coombes ME; Levine M; Cosby J; Kowaleski B; Arnold A
    Invest New Drugs; 2011 Oct; 29(5):1013-20. PubMed ID: 20512397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methods for causality assessment of adverse drug reactions: a systematic review.
    Agbabiaka TB; Savović J; Ernst E
    Drug Saf; 2008; 31(1):21-37. PubMed ID: 18095744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs?
    Macedo AF; Marques FB; Ribeiro CF
    Drug Saf; 2006; 29(8):697-702. PubMed ID: 16872243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clarification of terminology in drug safety.
    Aronson JK; Ferner RE
    Drug Saf; 2005; 28(10):851-70. PubMed ID: 16180936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug therapy and adverse drug reactions to terbutaline in obstetric patients: a prospective cohort study in hospitalized women.
    Hernández-Hernández D; Vargas-Rivera M; Nava-Ocampo AA; Palma-Aguirre J; Sumano-López H
    BMC Pregnancy Childbirth; 2002 Apr; 2(1):3. PubMed ID: 11934352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bayesian assessment of adverse drug reactions.
    Hutchinson TA
    CMAJ; 2000 Nov; 163(11):1463-4. PubMed ID: 11192652
    [No Abstract]   [Full Text] [Related]  

  • 56. Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people.
    Wilkinson TJ; Begg EJ; Winter AC; Sainsbury R
    Br J Clin Pharmacol; 1999 Feb; 47(2):211-7. PubMed ID: 10190657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Causal or casual? The role of causality assessment in pharmacovigilance.
    Meyboom RH; Hekster YA; Egberts AC; Gribnau FW; Edwards IR
    Drug Saf; 1997 Dec; 17(6):374-89. PubMed ID: 9429837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does proof of casualty ever exist in pharmacovigilance?
    Auriche M; Loupi E
    Drug Saf; 1993 Sep; 9(3):230-5. PubMed ID: 8240728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-related problems causing admission to a medical clinic.
    Bergman U; Wiholm BE
    Eur J Clin Pharmacol; 1981; 20(3):193-200. PubMed ID: 7286037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of two recently published algorithms for assessing the probability of adverse drug reactions.
    Busto U; Naranjo CA; Sellers EM
    Br J Clin Pharmacol; 1982 Feb; 13(2):223-7. PubMed ID: 7059419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.